Atlas Trials

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201)Alliance for Clinical Trials in Oncology2021-10-08
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma (NCT03501576)Emory University2018-04-06
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500)City of Hope Medical Center2017-05-25
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant (NCT02797470)AIDS Malignancy Consortium2016-06-23
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency (NCT01787409)Mayo Clinic2013-03-06
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709)National Cancer Institute (NCI)2012-04-16
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma (NCT01466881)National Cancer Institute (NCI)2011-10-01
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma (NCT01403415)National Cancer Institute (NCI)2011-09-01
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors (NCT01326702)National Cancer Institute (NCI)2011-07-01
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578)National Cancer Institute (NCI)2010-11-24
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)National Cancer Institute (NCI)2008-10-01
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00082888)National Cancer Institute (NCI)2004-03-24

Track Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.